1.Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

1.的观察滤过(HDF)及(HD)对尿毒症脑病的疗效。

2.The method basically has blood dialytic with peritonaeum dialytic two kinds.

2.方法主要有和腹膜两种。

3.To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

3.观察滤过(HDF)对老年患者心管稳定性的影响。

4.Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

4.摘要 摘要 的：了解和尿毒症对肿瘤标志物水平的影响。

5.Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

5.方法观察12例使用人造管内瘘的患者,针对其内瘘情况进护理。

6.Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

6.结论低钠症患者如果利尿效果不佳或合并有心力衰竭或高容量时,可以考虑治疗。

7.Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

7.的 提高对长期患者获得性肾囊肿及肾细胞癌的发病和临床特点的认识。

8.Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

8.的探讨影响出热病人急性肾衰少尿期预后的因素及在出热病人中的应用时机。

9.Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

9.的观察肾康注射治疗慢性肾功能衰竭的疗效,为控制慢性肾衰患者肾衰进程而延缓进提供一个好的方法。